www.journalonsurgery.org

Short Commentary

Open Access, Volume 4

Cost-Minimization Analysis of Robotic Versus LaparoscopicAssisted Liver Cancer Resection

Taslim Aboudou1,2,3,4; Meixuan Li2,3; Yanfei Li2,3; Hassan Idris Abdu4; Lutfi Edress Abdu Mohamad5; Dan Wang4; Wang Yiyang4; Liu Tianyu4; Kehu Yang1,2,3*

1The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.
2Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
3Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, 730000, China.
4College of Health Management, Shangluo University, Shangluo, 70000, Shaanxi, China.
5University of Shandi, Shandi State, Sudan.

Abstract

Background: In the treatment of patients with liver cancer, laparoscopic liver cancer resection is the earliest and most widely used minimally invasive surgery. Robotic surgery technology helps surgeons overcome the shortcomings of traditional laparoscopic surgery by providing surgeons with high-resolution 3D images, wrist instruments that provide degrees of freedom, and tremor filtering technology.

Objective: We designed a cost-minimization analysis to explore the cost difference of roboticassisted versus laparoscopic-assisted liver cancer resection, so as to provide the valuable reference for clinical practice and patients.

Results: A total of 51 patients performed with liver cancer were carefully chosen from Gansu Provincial People’s Hospital, which included eighteen patients with robot-assisted hepatectomy and thirty-three patients with laparoscopic-assisted hepatectomy.

The Cost-minimization analysis showed that the average medical cost per patient receiving robotic surgery was 60,322 yuan, and the average medical cost per patient receiving laparoscopic surgery was 46,867 yuan. Compared with robotic surgery, laparoscopic surgery could save 13,455 yuan.

Method: Cost-minimization analysis was designed to determine the best option economic for medical technology with the similarity of efficacy and safety for robotic hepatectomy and laparoscopic hepatectomy. Excel 2016 software was used to collect and analyze cost data. Oneway deterministic sensitivity analysis was performed to assess the uncertainty of the parameter (cost of operation, cost of medical materials, cost of adjuvant therapy, cost of medicine, cost of medical examination, cost of anesthesia, cost of health care, and cost of hospitalization) values and gauge the reliability and generalizability of the results.

Conclusion: The comparison between robotic-assisted liver surgery and laparoscopic surgery shows that the average medical cost was higher in robotic surgery when compared to laparoscopic liver cancer.

Keywords: Cost-minimization; Robotic; Laparoscopic-assisted; Liver; Cancer.

Manuscript Information: Received: Aug 21, 2023; Accepted: Jan 03, 2024; Published: Jan 10, 2024

Correspondance: Kehu Yang, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China. Email: kehuyangebm206@126.com

Citation: Aboudou T, Li M, Li Y, Idris Abdu H, Yang K, et al. Cost-Minimization Analysis of Robotic Versus Laparoscopic-Assisted Liver Cancer Resection. J Surgery. 2024; 4(1): 1140.

Copyright: © Yang K 2024. Content published in the journal follows creative common attribution license.

Introduction

Hepatocellular Carcinoma (HCC) was rated as the sixth cancer in the world [1,2], it has a high mortality rate [3-5]. The pathogenesis of HCC is mainly related to HBV or HCV infection. Hepatectomy is a surgical procedure that removes local lesions from the liver to retain a normal function of the liver group, mainly for the treatment of liver cancer and some benign liver diseases (such as hepatic angiosarcoma, hepatic dysplastic nodules, hepatic leiomyoma) [4,6,7]. In the treatment of patients with liver cancer, laparoscopic liver cancer resection is the earliest and most widely used minimally invasive surgery [8,9]. However, it also has limitations such as two-dimensional surgical field, limited movement of laparoscopic instruments, and inevitable physiological tremors [3,10-12]. Robotic surgery technology helps surgeons overcome the shortcomings of traditional laparoscopic surgery by providing surgeons with high-resolution 3D images, wrist instruments that provide degrees of freedom, and tremor filtering technology [13]. However, studies [14-16] found no significant difference between the robotic surgery group and the laparoscopic group in terms of transfusion rate, conversion rate, estimated blood loss, length of hospital stay, and reoperation rate. In this case, which with lower costs may be the best option. Cost-minimization identifies the lowest cost of treatments that have been shown to be otherwise equivalent in clinical effectiveness.

Therefore, we designed a cost-minimization analysis to explore the cost difference of roboticassisted versus laparoscopic-assisted liver cancer resection, so as to provide the valuable reference for clinical practice and patients.

Methods

Study design: Cost-minimization analysis was designed to determine the most economical option for the medical technology with the same efficacy and safety. Since the efficacy and safety of robotic-assisted and laparoscopic liver cancer resection are comparable, this study aims to compare the costs of the two surgical methods. The costs in economic evaluation include direct costs, indirect costs and hidden costs. This study only compares the direct medical costs, including operation fee, medical materials fee, adjuvant therapy fee, medicine fee, medical examination fee, anesthesia fee, health care fee, and hospitalization fee. All costs are in 2022 RMB.

Data source

The purpose of this study is to reflect the situation in the real world. We investigated liver cancer patients from Gansu Provincial People’s Hospital, including adult patients with robot assisted liver cancer resection and patients with laparoscopic assisted liver cancer resection.

Statistical analyses

This study uses excel 2016 software to collect and analyze cost data. The analysis outcomes include the total costs of per patient undergoing robotic surgery and laparoscopic surgery, and the average costs of per patient in each cost item, including operation fee, medical materials fee, adjuvant therapy fee, medicine fee, medical examination fee, anesthesia fee, health care fee, and hospitalization fee.

One-way deterministic sensitivity analysis was performed to assess the uncertainty of the parameter values and gauge the reliability and generalizability of the results. The parameters included: cost of operation, cost of medical materials, cost of adjuvant therapy, cost of medicine, cost of medical examination, cost of anesthesia, cost of health care, and cost of hospitalization.

All parameters were subjected to ±10%, and assuming they were all independent of each other.

Results

Fifty-one patients with liver cancer were selected from Gansu Provincial People’s Hospital, including 18 patients with robot assisted hepatectomy and 33 patients with laparoscopic assisted hepatectomy. The Cost-minimization analysis showed that the average medical cost of per patient receiving robotic surgery was 60,322 yuan, and the average medical cost of per patient receiving laparoscopic surgery was 46,867 yuan. Compared with robotic surgery, laparoscopic surgery could save 13,455 yuan. The operation fee, medical materials fee, other adjuvant therapy fee and health care fee of robotic surgery are higher than those of laparoscopic surgery. However, the medicine fee, medical examination fee, anesthesia fee and hospitalization fee of laparoscopic surgery are slightly higher than those of robotic surgery. Among them, the biggest difference is the ooperation fee, which is 16,915 yuan for robotic surgery and 6467 yuan for laparoscopic surgery, the difference is 10,448 yuan. See Table 1 and Figure 1.

Table 1: Clinicopathological characteristics of PEACs in comparison with MCC.
Cost item Robotic
hepatectomy
(¥)
Laparoscopic
hepatectomy
(¥)
Cost
(¥)
Saving
Proportion of
cost saving (%)
Operation 16,915 6467 10,448 78%
Medical materials 13,524 11,842 1682 13%
Adjuvant therapy 9796 4959 4837 36%
Medicine 9244 10,718 -1474 -11%
Medical examination 7416 9090 -1674 -12%
Anesthesia 2046 2274 -228 -2%
Health care 842 802 40 0%
Hospitalization 539 715 -176 -1%
Total cost 60,322 46,867 13,455 100%
Figure 1: Costs difference of robotic assisted versus laparoscopic hepatectomy.

Figure 2: Tornado diagram depicting the results of one-way sensitivity analyses.

Sensitivity analyses showed cost of robotic-assisted operation and medical materials had a significant impact on the results (Figure 2).

Discussion

Since the introduction of the robotic surgery, there has been a push to demonstrate the effectiveness and safety of roboticassisted over the conventional laparoscopic liver cancer resection [17-19]. The Cost-minimization analysis showed that the average medical cost of per patient receiving robotic surgery was higher than receiving laparoscopic liver cancer resection. Compared with robotic surgery, laparoscopic surgery could save 13,455 yuan. The biggest difference is the operation fee, which is 16,915 yuan for robotic surgery and 6467 yuan for laparoscopic surgery, the difference is 10,448 yuan.

Although this study indicated that robot-assisted liver cancer resection maybe more expensive than laparoscopic liver cancer resection, clinical clinicians and patients should consider more factors when deciding whether to choose robotic assisted liver cancer resection. Currently, an increasing number of studies have investigated the clinical outcomes of robot-assisted liver cancer resection versus laparoscopic and open liver cancer resection, however, the evidence of cost analyses was lacking, and the results of the limited evidence was inconsistent. Wu et al analyzed 100 patients and indicated that the robotic group incurred higher peri-operative expenses, while the cost of inpatient care was lower than open surgery group [7]. One study from USA indicated that the operative cost was significantly higher in the robotic group, while overall admission cost was comparable between robotic and conventional open hepatectomy [20]. A meta-analysis including 29 studies (537 patients) indicated that the cost of the laparoscopic liver cancer resection was greater than robotic surgery, the results was conflict with our results, it should be interpreted with caution. Therefore, more research are needed to further analyze the costs of robot-assisted, laparoscopic, and open liver cancer resection in the future.

Due to a number of technological advancements, including greater visibility, increased angulation and range of motion, and more precise suturing, robotic surgical systems are better than laparoscopic devices [20-24]. Robotic surgical systems are now employed in a wide range of operations and specialties, such as head and neck surgery, urology, endocrine surgery, metabolic and bariatric surgery, and all intra-abdominal surgery subspecialties [25-27]. Additionally, the number of patients undergoing robotic surgery is rising quickly. Because of limited evidence of the efficacy, safety, and economic evaluation of robotic assisted liver cancer resection versus laparoscopic liver cancer resection, in the future, more high-quality studies are needed to further explore the advantages and disadvantages of robot-assisted liver cancer resection versus laparoscopic liver cancer resection.

Limitations

There are several limitations of this study. On the one hand, our data source are limited and only from one single hospital in Lanzhou of China, a broader range of evidence is needed to support clinical practice in the future; On the other hand, this study assumed that the efficacy of robot assisted liver cancer resection and laparoscopic liver cancer resection were consistent, but the efficacy and safety outcomes we analyzed were limited, some long-term outcomes, such as overall survival, and incidence of adverse events, were not analyzed. Therefore, future studies in this area are needed.

Conclusion

Limited data showed that the average medical cost of roboticassisted liver cancer resection was higher than laparoscopic liver cancer resection. The difference is mainly due to the operation fee. To further analyze the advantages and disadvantages of robotic-assisted and laparoscopic liver cancer resection, high-quality cost-effectiveness analysis is needed in the future.

Declarations

The authors declare no conflicts of interest.

No funding was received for writing this manuscript.

References

  1. Salloum C, et al. Robotic-assisted versus laparoscopic left lateral sectionectomy: Analysis of surgical outcomes and costs by a propensity score matched cohort study. World journal of surgery. 2017; 41: 516-524.
  2. Magistri P, et al. Robotic vs open distal pancreatectomy: A multi‐institutional matched comparison analysis. Journal of Hepato‐Biliary‐Pancreatic Sciences. 2021; 28: 098-1106.
  3. Wu YM, et al. Robotic-assisted minimally invasive liver resection. Asian J Surg. 2014; 37: 53-7.
  4. Wong DJ, et al. Systematic review and meta-analysis of robotic versus open hepatectomy. ANZ J Surg. 2019; 89: 165-170.
  5. Ziogas IA, et al. Laparoscopic versus robotic major hepatectomy: A systematic review and meta-analysis. 2021; 35: 524-535.
  6. Yan Y, Cai X, DA Geller. Laparoscopic Liver Resection: A Review of Current Status. J Laparoendosc Adv Surg Tech A. 2017; 27: 481-486.
  7. Wu CY, et al. Is robotic hepatectomy cost-effective? In view of patient-reported outcomes. Asian J Surg. 2019; 42: 543-550.
  8. Wang WH, et al. Oncological and surgical result of hepatoma after robot surgery. Surg Endosc. 2018; 32: 3918-3924.
  9. Wang H, et al. A historical review and bibliometric analysis of GPS research from 1991-2010. 2013; 95: 35-44.
  10. Troisi RI, et al. Robot assistance in liver surgery: A real advantage over a fully laparoscopic approach? Results of a comparative bi‐institutional analysis. The International Journal of Medical Robotics and Computer Assisted Surgery. 2013; 9: 160-166.
  11. Sucandy I, et al. Robotic hepatectomy for benign and malignant liver tumors. J Robot Surg. 2020; 14: 75-80.
  12. Spampinato MG, et al. Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: An Italian multi-institutional comparative study. Surg Endosc. 2014; 28: 2973-9.
  13. Prueksapanich P, et al. Liver Fluke-Associated Biliary Tract Cancer. 2018; 12: 236 - 245.
  14. Salloum C, et al. Robotic-Assisted Versus Laparoscopic Left Lateral Sectionectomy: Analysis of Surgical Outcomes and Costs by a Propensity Score Matched Cohort Study. World J Surg. 2017; 41: 516-524.
  15. Thun MJ, et al. Lung cancer. 2018: 519-542.
  16. Tsung A, et al. Robotic versus laparoscopic hepatectomy: A matched comparison. Ann Surg. 2014; 259: 549-55.
  17. Liu R, et al. International consensus statement on robotic hepatectomy surgery in 2018. World J Gastroenterol. 2019; 25: 1432-1444.
  18. Lim C, et al. Short- and Long-term Outcomes after Robotic and Laparoscopic Liver Resection for Malignancies: A Propensity ScoreMatched Study. World J Surg. 2019; 43: 1594-1603.
  19. Leung U, Y Fong. Robotic liver surgery. Hepatobiliary Surgery and Nutrition. 2014; 3: 288-294.
  20. Hawksworth J, et al. Robotic Hepatectomy Is a Safe and Cost-Effective Alternative to Conventional Open Hepatectomy: a Single-Center Preliminary Experience. J Gastrointest Surg. 2021; 25: 825-828.
  21. Lai ECH, et al. Robotic hepatectomy for hepatocellular carcinoma: A clinical review % J Hepatoma Research. 2017; 3.
  22. Kingham TP, et al. Robotic Liver Resection: A Case-Matched Comparison. World J Surg. 2016; 40: 1422-8.
  23. Kang CM, et al. The first Korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da Vinci system. Yonsei medical journal. 2007; 48: 540-545.
  24. Gavriilidis P, et al. A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network metaanalysis. Eur J Surg Oncol. 2020; 46: 1214-1224.
  25. Lee SJ, et al. The feasibility of robotic left-side hepatectomy with comparison of laparoscopic and open approach: Consecutive series of single surgeon. Int J Med Robot. 2019; 15: e1982.
  26. Lee KF, et al. Robotic Liver Resection For Primary Hepatolithiasis: Is It Beneficial? World J Surg. 2016; 40: 2490-6.
  27. Lee KF, et al. Robotic versus open hemihepatectomy: a propensity score-matched study. Surg Endosc. 2021; 35: 2316-2323.